Ceren Karaman1, Bahar Bankoğlu Yola2, Onur Karaman3, Necip Atar4, İlknur Polat5, Mehmet Lütfi Yola6. 1. Department of Electricity and Energy, Vocational School of Technical Sciences, Akdeniz University, Antalya, Turkey. 2. Science and Technology Application and Research Laboratory, Iskenderun Technical University, Hatay, Turkey. 3. Department of Medical Imaging Techniques, Vocational School of Health Services, Akdeniz University, Antalya, Turkey. 4. Department of Chemical Engineering, Faculty of Engineering, Pamukkale University, Denizli, Turkey. 5. Department of Nutrition and Dietetics, Faculty of Health Sciences, Hasan Kalyoncu University, Gaziantep, Turkey. 6. Department of Nutrition and Dietetics, Faculty of Health Sciences, Hasan Kalyoncu University, Gaziantep, Turkey. mlutfi.yola@hku.edu.tr.
Abstract
A sensitive and fast sandwich-type electrochemical SARS-CoV‑2 (COVID-19) nucleocapsid protein immunosensor was prepared based on bismuth tungstate/bismuth sulfide composite (Bi2WO6/Bi2S3) as electrode platform and graphitic carbon nitride sheet decorated with gold nanoparticles (Au NPs) and tungsten trioxide sphere composite (g-C3N4/Au/WO3) as signal amplification. The electrostatic interactions between capture antibody and Bi2WO6/Bi2S3 led to immobilization of the capture nucleocapsid antibody. The detection antibody was then conjugated to g-C3N4/Au/WO3 via the affinity of amino-gold. After physicochemically characterization via transmission electron microscopy (TEM), scanning electron microscopy (SEM), x-ray diffraction (XRD), and x-ray photoelectron spectroscopy (XPS), cyclic voltammetry (CV), differential pulse voltammetry (DPV), and electrochemical impedance spectroscopy (EIS) analysis were implemented to evaluate the electrochemical performance of the prepared immunosensor. The detection of SARS-CoV-2 nucleocapsid protein (SARS-CoV-2 NP) in a small saliva sample (100.0 µL) took just 30 min and yielded a detection limit (LOD) of 3.00 fg mL-1, making it an effective tool for point-of-care COVID-19 testing.
A sensitive and fast sandwich-type electrochemical SARS-CoV‑2 (COVID-19) nucleocapsid protein immunosensor was prepared based on bismuth tungstate/bismuth sulfide composite (Bi2WO6/Bi2S3) as electrode platform and graphitic carbon nitride sheet decorated with gold nanoparticles (Au NPs) and tungsten trioxide sphere composite (g-C3N4/Au/WO3) as signal amplification. The electrostatic interactions between capture antibody and Bi2WO6/Bi2S3 led to immobilization of the capture nucleocapsid antibody. The detection antibody was then conjugated to g-C3N4/Au/WO3 via the affinity of amino-gold. After physicochemically characterization via transmission electron microscopy (TEM), scanning electron microscopy (SEM), x-ray diffraction (XRD), and x-ray photoelectron spectroscopy (XPS), cyclic voltammetry (CV), differential pulse voltammetry (DPV), and electrochemical impedance spectroscopy (EIS) analysis were implemented to evaluate the electrochemical performance of the prepared immunosensor. The detection of SARS-CoV-2 nucleocapsid protein (SARS-CoV-2 NP) in a small saliva sample (100.0 µL) took just 30 min and yielded a detection limit (LOD) of 3.00 fg mL-1, making it an effective tool for point-of-care COVID-19 testing.
The recent coronavirus disease (COVID-19), which the World Health Organization (WHO) has proclaimed as a pandemic, has a significant impact on not just health but also the economy [1-3]. Therefore, the WHO urged the international community to conduct widespread diagnostic testing in an effort to fight against the virus spread and reduce the number of cases that go undetected [4]. The tools for diagnostic are critical in determining early treatment and isolation decisions for affected people, preventing or halting the spread of infectious diseases. As a consequence, developing a highly-sensitive, precise, and prompt diagnostics tools can be vital in deciding what is best about whether or not to isolate affected individuals, thereby controlling the spread rate of this fatal virus [4-6]. The “gold standard” technique in detecting severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that leads COVID-19 can be regarded as the reverse-transcription polymerase chain reaction (RT-PCR) [7]. Although PCR-based tests seem to be specifically tailored for SARS-CoV-2, many variables, including sample variances and viral RNA persistence in the nasal cavity/throat, impact their accuracy, resulting in false-negative/false-positive test findings [8-10]. Furthermore, radiological imaging techniques like computed tomography (CT) are considered to be one of the most effective ways to detect the COVID-19. However, owing to some constraints such as being available only at health facilities, difficulties in accessibility, and high cost, it is unlikely to be utilized for swift and large-scale testing [11, 12]. Therefore, the development of time-saving, extremely sensitive, and precise, cost-effective COVID-19 electroanalytical sensing technologies is essential and would have a substantial impact on the control of the pandemic [13].There has recently been a drive to fabricate COVID-19 serological assays that identify immunological or viral proteins in the blood sample of infected people. Since proteins are homogenously distributed in the blood, serological specimens are more persistent than viral RNA and have fewer variations than nasopharyngeal or oropharyngeal viral RNA specimens, reducing the risk of false-negative test findings [14]. In a few publications, it has been established that lateral flow immunoassay (LFA) methods incorporating colorimetry/fluorescence approaches for targeting the IgG, IgM, or IgA immunoglobulins generated as a reaction to SARS-CoV-2 during the early stages of infection may accurately diagnose viral RNA [8, 15–21]. Moreover, the serological assays will aid in assessing a population’s immunological response to spontaneous infection as well as vaccination [7]. Despite the fact that these devices are user-friendly and swift, they generally have low sensitivity and need at least two antibodies to detect. Therefore, electrochemical monitoring of SARS-CoV-2 antibodies has emerged as a viable approach to solve these limitations [7]. This technique has a high ability to distinguish tiny differences on the electrode surface from the recognition case, thereby allowing label-free detection without any need for a single antibody. Electrochemical immunosensors have significant features that are appropriate for today’s needs, such as simplicity of use, cost and time effectiveness, portability, swiftness, and high sensitivity [13]. Previously, various electrochemical biosensors were employed to detect viral antigens from a variety of fatal viruses, including Hepatitis, Dengue, Rabies, and Zika [22-24]. Moreover, due to the current COVID-19 pandemic, biosensor research aimed at identifying and quantifying SARS-CoV-2 has emerged. However, interfacial contamination caused by biomolecule adsorption is one of the most serious challenges with electrochemical sensing technologies, limiting their practical applicability [25]. Therefore, the fabrication of an effictice immunosensor surface modified with suitable nanomaterials, which restricts non-specific adsorption of molecules without interacting with particular analyte detection, is one plausible option to this challenge.Semiconductor nanocrystals were used for various applications such as energy [26], supercapacitor electrode material [27, 28], and catalysis [29]. Especially, bismuth-based semiconductors having specific morphology show desirable sensor catalytic performance [30, 31]. Among these semiconductors, bismuth sulfide (Bi2S3) belonging a tunable band gap (from 1.2 to 1.8 eV) demonstrates good stability, non-toxicity, and conductivity, providing superior electronic properties for sensor/biosensor applications. Nonetheless, owing to the easy photogenerated carrier recombination, its practical applications are limited. In order to eliminate this carrier recombination problem, the several methods such as the element dopping and the preparation of heterostructures can be utilized for improvement of catalytic activity. The layered Bi2WO6 has received a great deal of interest thanks to its stability and superior catalytic properties [32]. Its layered structure composes of the octahedral (WO4)2− sheets and bismuth oxide (Bi2O2)2+ layers, indicating easy charge transfer. This structure was formed by an intergrowth of WO42− ions between (Bi2O2)2+ layers [33]. Due to internal electric field, the recombination of charge carriers is reduced and sensor/biosensor’s catalytic activity increases. In addition, its application areas can be expanded by dopping treatment [34] and the heterojunction construction [35]. In these methods, the coupling with two different semiconductor into heterojunctions is effective approach [36]. Thus, we prepared Bi2WO6/Bi2S3 as electrode platform in this study.The preparation of g-C3N4 can be carried out by thermal pyrolysis of nitrogen-rich precursors such as melamine and urea [37]. Due to its excellent stability, low toxicity and conductivity, it has been utilized in electrochemical applications [38]. g-C3N4 with band gap of 2.7 eV and WO3 with band gap of 2.8 eV can be made up of a Z-scheme heterojunction [39], providing the prevention of the electron–hole recombination. In addition, tungsten trioxide (WO3) has superior electronic and chemical properties and biocompatibility [40]. A mediator such as AuNPs is generally needed for facilitating the electron transfer in Z-scheme heterojunction. Due to AuNPs’ electrical conductivity and large specific surface area, the immobilization of antibodies also becomes easier [41]. Hence, g-C3N4/Au/WO3 as signal amplification can separate electron–hole, providing the sensitivity of sensor performance.Herein, in the light of all aforementioned points in mind, it was aimed to fabricate a novel electrochemical SARS-CoV‑2 nucleocapsid protein immunosensor based on Bi2WO6/Bi2S3 and g-C3N4/Au/WO3 for COVID-19 detection for the first time in literature. The fabricated immunosensor provides a number of benefits, including ease of use, speed, and selectivity. Moreover, a precise LOD of 3.00 fg mL−1 was acquired with high selectivity and no interference in saliva samples. Hence, the fabricated electrochemical SARS-CoV‑2 nucleocapsid protein immunosensor presents a new perspective in the point-of-care COVID-19 testing.
Experimental section
Materials
SARS-CoV-2 NP, capture human monoclonal anti-SARS-CoV-2 nucleocapsid antibody (c-SARS-CoV-2-Ab1), detection monoclonal anti-SARS-CoV-2 nucleocapsid antibody (d-SARS-CoV-2-Ab2), MERS-CoV nucleocapsid protein (MERS-CoV NP), coronavirus nucleoprotein (SARS-CoV NP), influenza A antigen (H1N1), Bi(NO3)3·5H2O, Na2S·9H2O, carbamide, Na2WO4·2H2O, melamine, sodium borohydride (NaBH4), and chloroauric acid (HAuCl4) were supplied from Sigma-Aldrich. Moreover, during the experiments, 0.1 mol.L−1 phosphate-buffered saline (PBS) solution with a pH value of 7.0 was employed as a supporting electrolyte and diluting buffer solution.
Apparatus for evaluation of nanomaterials
Surface morphological characteristics were explored by using a SEM (ZEISS EVO 50) SEM and a TEM (JEOL 2100). X-ray spectrum of nanostructrues was collected by a Rigaku X-ray diffractometer with Cu-K radiation (λ = 0.150 nm). The PHI 5000 Versa Probe spectrometer was used to perform the XPS survey. UV–Vis and Raman measurements were performed by Mettler Toledo and LabRam HR Raman Spectrometer, respectively. Electrochemical characterization techniques such as cyclic voltammetry, differential pulse voltammetry, and electrochemical empdance spectroscopy were also conducted via the Gamry Reference 600 workstation (Gamry, USA).
Preparation of Bi2WO6, Bi2S3, and Bi2WO6/Bi2S3
For preparation of Bi2S3 nanorods, the addition of Bi(NO3)3·5H2O (1.90 g) into ethanol solution (30.0 mL) was firstly performed and stirred during 30 min. Then, Na2S·9H2O aqueous solution (0.1 g mL−1) was prepared, stirred during 45 min and slowly added into Bi(NO3)3·5H2O solution, providing the black suspension. After that, carbamide solution (0.1 g mL−1) was transferred into the above solution and the suspension was subjected to 200 °C for 20 h in a Teflon steel autoclave. Bi2S3 nanorods were filtered, washed, and dried at 25.0 °C.For preparation of Bi2WO6, the mixture of Na2WO4·2H2O (3.0 mmol, 10.0 mL) and Bi(NO3)3·5H2O (3.0 mmol, 10.0 mL) was prepared and strongly stirred during 20 min. Then, the mixture was subjected to 200 °C for 15 h in a Teflon steel autoclave. The resulting product as Bi2WO6 was filtered, washed, and dried at 60.0 °C.To prepare Bi2WO6/Bi2S3 composite, Bi2S3 nanorods (10.0 mmol) and Bi2WO6 (10.0 mmol) were mixed at 1:1, v/v for 40 min. After that, Bi2WO6/Bi2S3 composite having heterojunction was collected, filtered, and dried at 40 °C.
Bi2WO6/Bi2S3 modified GCE (Bi2WO6/Bi2S3/GCE) as electrochemical sensor platform with c-SARS-CoV-2-Ab1 and SARS-CoV-2 NP immobilizations
The glassy carbon electrode (GCE) was prepared as follows to be utilized in the further steps [42]: firstly, 0.1 µm and 0.05 µm alumina slurries were transferred on cleaning pads, respectively. Then, the GCE was polished with these alumina slurries for 20 min. Subsequently, the electrodes were rinsed with isopropyl alcohol and acetonitrile, respectively to remove the alumina remains at 25 °C. The electrode modifications with Bi2WO6, Bi2S3, and Bi2WO6/Bi2S3 suspensions (10.0 μL, 0.1 mg mL−1) were performed by dropping these suspensions on the clean GCEs. After 20 min, the solvent removal was carried out by infrared heat lamp, providing Bi2WO6, Bi2S3, and Bi2WO6/Bi2S3 modified GCEs (Bi2WO6/GCE, Bi2S3/GCE, and Bi2WO6/Bi2S3/GCE). The c-SARS-CoV-2-Ab1 immobilization on Bi2WO6/Bi2S3/GCE was performed by dropping of 20 μL c-SARS-CoV-2-Ab1 dispersion (with a concentration of 20.0 μg.mL−1) on Bi2WO6/Bi2S3/GCE via strong electrostatic interactions between amino group of c-SARS-CoV-2-Ab1 and bismuth oxide (Bi2O2)2+. The electrodes were maintained at 37.0 °C for 15 min (c-SARS-CoV-2-Ab1/Bi2WO6/Bi2S3/GCE). Then, BSA (3.0% w/v) was incubated on c-SARS-CoV-2-Ab1/Bi2WO6/Bi2S3/GCE at 37.0 °C over 15 min to eliminate the non-specific interactions (BSA/c-SARS-CoV-2-Ab1/Bi2WO6/Bi2S3/GCE). Each of SARS-CoV-2 NP with different concentrations was incubated to BSA/c-SARS-CoV-2-Ab1/Bi2WO6/Bi2S3/GCE for 15 min at 37.0 °C via specific protein-antibody interactions (SARS-CoV-2 NP/BSA/c-SARS-CoV-2-Ab1/Bi2WO6/Bi2S3/GCE). Lastly, the whole electrode including SARS-CoV-2 NP and c-SARS-CoV-2-Ab1 was interacted with 0.1 M PBS (pH 7.0) to take away non-interacting SARS-CoV-2 nucleocapsid proteins.
Preparation of g-C3N4, g-C3N4/WO3, and g-C3N4/Au/WO3
Firstly, g-C3N4 preparation was performed [43]. For this aim, the calcination of melamine (20.0 g) was conducted at 500 °C over 90 min. After the cooling treatment at 25 °C, the obtained yellow product was transferred into the combustion boat and the calcination treatment was performed at 480 °C for 120 min and after cooling, the white g-C3N4 was obtained.For g-C3N4/WO3 preparation [44], the mixture of g-C3N4 (0.25 g), Na2WO4⋅2H2O (1.00 g), and ethanol (150.0 mL) was prepared under strong stirring. Afterward, the concentrated HCl (10.0 mL) was gently added into this mixture and the dispersion was calcined at 420 °C for 120 min, providing g-C3N4/WO3 composite.For g-C3N4/Au/WO3 preparation, the mixture of g-C3N4/WO3 (150.0 mg), HAuCl4 (50.0 μL, 20.0 mM), and ultra-pure water (50.0 mL) was prepared. After that, NaBH4 (2.0 mL, 20.0 mM) was added into this dispersion under strong stirring and g-C3N4/Au/WO3 was dried at 25 °C.
g-C3N4/Au/WO3 signal amplification with d-SARS-CoV-2-Ab2 conjugation
d-SARS-CoV-2-Ab2 conjugation was performed by addition of detection antibody (20.0 μL, 20.0 μg mL−1) into g-C3N4/Au/WO3 (20.0 μL, 20.0 mg mL−1) signal amplification via strong amino-gold affinity [45, 46]. After the vigorous stirring at 37.0 °C for 30 min, d-SARS-CoV-2-Ab2/g-C3N4/Au/WO3 was centrifugated at 5000 rpm for 30 min.
Electrochemical characterizations
The resulting SARS-CoV‑2 nucleocapsid protein immunosensor was constructed by antibody-nucleocapsid protein interactions between d-SARS-CoV-2-Ab2/g-C3N4/Au/WO3 and SARS-CoV-2 NP/BSA/c-SARS-CoV-2-Ab1/Bi2WO6/Bi2S3/GCE. By drop-casting method, 20.0 μL d-SARS-CoV-2-Ab2/g-C3N4/Au/WO3 dispersion (with a concentration of 20.0 mg mL−1) was coated on electrode surface such as SARS-CoV-2 NP/BSA/c-SARS-CoV-2-Ab1/Bi2WO6/Bi2S3/GCE, at a 30 min immunological response time. The final electrochemical immunosensor was tagged as g-C3N4/Au/WO3/d-SARS-CoV-2-Ab2/SARS-CoV-2 NP/BSA/c-SARS-CoV-2-Ab1/Bi2WO6/Bi2S3/GCE and this electrochemical immunosensor was stored in 0.1 M PBS (pH 7.0, 3.0 mL) without pressure fluctuations at 25 °C. The electrochemical performance of the SARS-CoV‑2 nucleocapsid protein immunosensor was monitored in 0.1 M PBS (pH 7.0, 2.0 mL) containing 1.0 mM H2O2 solution in the range of + 0.0/ + 0.4 V. Scheme 1 shows the preparation procedure of electrochemical SARS-CoV-2 immunosensor including the preparations of electrode platform and signal amplification.
Scheme 1
Schematic illustration of the fabrication procedure of electrochemical SARS-CoV-2 immunosensor
Schematic illustration of the fabrication procedure of electrochemical SARS-CoV-2 immunosensor
Processing of samples
The saliva samples were acquired from five healthy individuals (See S. M. for a further description of sample processing).
Results and discussion
Fundamental of electrochemical SARS-CoV-2 NP immunosensor based on Bi2WO6/Bi2S3 and g-C3N4/Au/WO3
Bi2WO6/Bi2S3 was employed as a sensor platform in immunosensor fabrication. Bi2WO6 with a layered structure comprises WO42− ions’ intergrowth between (Bi2O2)2+ layers. Due to the layered structure, Bi6s and O2p levels create the dispersed valence band, providing the catalytic effect [47]. In addition, Bi2WO6 has important function as a framework to prepare Bi2WO6/Bi2S3 composite. Sodium sulfide as sulfur source can release S2− ion to react with Bi2WO6 via ion change, providing Bi2S3 nanorods’ dispersion [33]. In immunosensor construction, the efficient electrostatic interactions between amino group of c-SARS-CoV-2-Ab1 and Bi2WO6/Bi2S3 composite also provided the strong capture antibody immobilization on electrode surface.g-C3N4/Au/WO3 composite was used as a signal amplification for electrochemical SARS-CoV-2 NP immunosensor. This composite composed a Z-scheme heterojunction [39], resulting in the decrease of the electron transfer. Hence, a mediator, which facilitated electron transfer, is necessary at the interface of heterojunction. AuNPs can be a candidate intermediate owing to their large specific surface area, the ability of the charge separation promotion, and the antibody’s easy immobilization [48]. Hence, g-C3N4/Au/WO3 composite both integrates substantial benefits and efficiently facilitates electron transport, thereby resulting in the development of a sensitive immunosensor.Finally, H2O2 was utilized as a redox probe in this work due to its easy oxidation into O2 and continuous monitoring. The related electrochemical reaction mechanism for H2O2 in potential range was also provided on Scheme 1 as H2O2 ↔ O2 + 2H+ + 2e− [49, 50].
Characterizations of Bi2WO6, Bi2S3, and Bi2WO6/Bi2S3
The morphological features of Bi2WO6, Bi2S3, and Bi2WO6/Bi2S3 composite were investigated on Fig. 1. The nanoflower and ultrathin nanosheet morphological structure of Bi2WO6 with about 2.5 μm diameter and 490–510 nm length were shown on Fig. 1A. Figure 1B shows pure Bi2S3 having a nanorod structure with width of 35–45 nm. In addition, the deposition of Bi2S3 nanorods with 120–140 nm lengths on Bi2WO6 nanoflower was shown on Fig. 1C. Finally, the elemental mapping of composite material (Fig. 1D) confirmed Bi2WO6/Bi2S3 formation in presence of Bi, W, and S. Secondly, XPS analysis was carried out to show the analysis patterns of Bi2WO6, Bi2S3, and Bi2WO6/Bi2S3 (Fig.S1AS1 ). According to Fig. S1A, Bi 4f7/2 peaks at 157.8 and 163.7 eV, Bi 4f5/2 peaks at 158.8 and 164.1 eV, and S 2p3/2 peak at 161.2 eV verified the presence of Bi3+ and S2−, respectively. In addition, the peaks at 34.9 and 37.3 eV were ascribed to W 4f7/2 and W 4f5/2, respectively. Then, XRD patterns of Bi2WO6, Bi2S3, and Bi2WO6/Bi2S3 were demonstrated on Fig. S1B. The characteristic XRD peaks belonging to Bi2WO6 and Bi2S3 were attributed to the orthorhombic phases of Bi2S3 and Bi2WO6 [51, 52]. The same XRD peaks on the patterns of Bi2WO6 and Bi2S3 were observed on XRD pattern of Bi2WO6/Bi2S3 and it is concluded that Bi2WO6/Bi2S3 was prepared with a high purity.
Fig. 1
SEM images of A Bi2WO6, B Bi2S3, and C Bi2WO6/Bi2S3; D elemental mapping of Bi2WO6/Bi2S3 composite
SEM images of A Bi2WO6, B Bi2S3, and C Bi2WO6/Bi2S3; D elemental mapping of Bi2WO6/Bi2S3 compositeAccording to Raman spectra (Fig. 2A), the obvious peaks such as the symmetric and asymmetric stretching peaks between W and O atoms on Bi2WO6 in 600–1000 cm−1 region were observed. Moreover, the band observed at 308 cm−1 was corresponded to O–WO– group’s bending, whereas the bands detected at 788 and 822 cm−1 were ascribed to asymmetrical and symmetrical modes of O–WO groups, respectively [53, 54]. The asymmetrical bridging mode relating to the tungstate chain was confirmed by the peak at 698 cm−1. On Raman spectra of Bi2WO6/Bi2S3, the novel peaks at 101 and 229 cm−1 and the increased peak intensity at 254 cm−1 confirmed the presence of Bi2S3 on composite [55]. In addition, the specific bands attributing to Bi2WO6 were observed on Raman spectra of Bi2WO6/Bi2S3. Figure 2B demonstrates UV–Vis spectra of Bi2WO6, Bi2S3, and Bi2WO6/Bi2S3. The absorption band at about 440 nm showed the characteristic response of Bi2WO6 and the extended light absorption on the spectrum of Bi2WO6/Bi2S3 confirmed the synergistic effect between Bi2WO6 and Bi2S3 [56].
Fig. 2
Raman (A) and B UV–Vis spectra of Bi2WO6, Bi2S3, and Bi2WO6/Bi2S3
Raman (A) and B UV–Vis spectra of Bi2WO6, Bi2S3, and Bi2WO6/Bi2S3
Characterizations of g-C3N4, g-C3N4/WO3, and g-C3N4/Au/WO3
The crystalline structures and the surface morphologies of g-C3N4, g-C3N4/WO3 and g-C3N4/Au/WO3 were examined by TEM, SEM, XRD, and XPS techniques. The wrinkle structure of g-C3N4 was shown on Fig. 3A. According to Fig. 3B, it was revealed that WO3 spheres with a diameter of 280–320 nm were uniformly decorated on g-C3N4 sheet, and AuNPs (red circle) with a small diameter placing between g-C3N4 and WO3 were deposited on g-C3N4/WO3 sheet (Fig. 3C). Furthermore, an EDX image of g-C3N4/Au/WO3 revealed the existence of C, N, O, W, and Au elements, noting that the g-C3N4/Au/WO3 was successfully fabricated (Fig. 3D). Finally, high-resolution TEM image (Fig. 3E) of g-C3N4/Au/WO3 demonstrated the lattice spacing of Au NP (pink circle) and WO3 (red circle), indicating 0.272 and 0.212 nm which were attributed to WO3 (022) [57] and Au (200) [58].
Fig. 3
A SEM image of g-C3N4, TEM images of B and C g-C3N4/Au/WO3, D EDX image of g-C3N4/Au/WO3, and E high-resolution TEM image of g-C3N4/Au/WO3
A SEM image of g-C3N4, TEM images of B and C g-C3N4/Au/WO3, D EDX image of g-C3N4/Au/WO3, and E high-resolution TEM image of g-C3N4/Au/WO3The chemical states and the surface functionalities of g-C3N4/Au/WO3 were examined through XPS analysis (Fig. S2). According to Fig. S2A of the survey spectra, the peaks belonging to C, N, O, W, and Au elements confirmed the successful preparation of g-C3N4/Au/WO3 in harmony with Fig. 3D [59]. The high-resolution C1s XRD spectra of sample deconvoluted into two main peaks at 285.1 eV and 288.1 eV corresponded to C–C bond and N–C groups (Fig. S2B) [60]. Moreover, N1s spectra (Fig. S2C) were deconvoluted into three main N configurations with the peaks detected at 398.1, 399.4, and 401.1 eV attributing to C–N–C, –N = C–, and N–H, respectively [60]. The peak at 530.1 eV attributing to lattice oxygen and the peak at 532.2 eV corresponding to the chemisorbed oxygen species in WO3 were demonstrated on Fig. S2D [61]. Fig.S2E relating to W 4f shows that W 4f7/2 and W 4f5/2 of W6+ were located at 35.1 and 37.9 eV, respectively [62]. Finally, the peaks at 84.1 and 88.1 eV were attributed to Au 4f7/2 and 4f5/2, respectively, indicating the existence of Au in composite material (Fig. S2F) [63].The crystal structure of g-C3N4/Au/WO3 composite was investigated by XRD (Fig. S3A). (002) crystal plane of g-C3N4 was confirmed by the peak at 27.62°. After the preparation of g-C3N4/Au composite, a new XRD peak at 38.31° was corresponded to Au NPs’ (111) plane [64] and all peaks belonging to WO3 were attributed to the monoclinic phase of WO3 [65]. The observed peaks on XRD patterns of g-C3N4/WO3 and g-C3N4/Au/WO3 were similar to that of WO3. In addition, the peak at 27.62° verified the presence of g-C3N4 and WO3. Nonetheless, the specific peaks of Au NPs were not observed on XRD pattern of g-C3N4/Au/WO3 composite, suggesting the low amount of Au NPs. UV–Vis spectra (Fig. S3B) were also recorded for g-C3N4, g-C3N4/WO3, and g-C3N4/Au/WO3. g-C3N4/Au/WO3 composite having a wide absorption range effectively absorbs light, providing the increased catalytic response.
Evaluation of the electrochemical characteristics of sensor platform and signal amplification
Firstly, the electrochemical investigations for the prepared sensor platform were progressively performed by using CV and EIS methods in presence of 1.0 mM [Fe(CN)6]3−/4− as redox pair. Firstly, the anodic and cathodic signals on bare GCE were observed at Epa = 550 mV and Epc = 375 mV, respectively, (curve a of Fig. 4A). Due to the high stability and catalytic activity of Bi2WO6/GCE in the presence of 1.0 mM [Fe(CN)6]3−/4−, more visible electrochemical signals were observed in contrast to bare glassy carbon electrode (curve b of Fig. 4A) [32]. Then, there was more electrochemical catalytic effect on the signals (curve c of Fig. 4A) by using Bi2S3/GCE, indicated the narrow band gap (1.3 eV) and the easy charge separation property [66]. Because Bi2WO6/Bi2S3 composites improved catalytic activity and the improved electron separation and transfer, the highest electrochemical responses in comparison with Bi2S3/GCE were obtained on Bi2WO6/Bi2S3/GCE (curve d of Fig. 4A). Electroactive surface areas of the prepared electrode surfaces were calculated as 0.173 ± 0.002 cm2 for bare GCE, 0.319 ± 0.001 cm2 for Bi2WO6/GCE, 0.647 ± 0.003 cm2 for Bi2S3/GCE, and 1.113 ± 0.006 cm2 for Bi2WO6/Bi2S3/GCE in the presence of 1.0 mM [Fe(CN)6]3− solution by i = 2.69 × 105 A n3/2 D1/2 C v1/2, where ip was current, C (mol cm−3) was [Fe(CN)6]3− concentration, v was scan rate (10–500 mV s−1), and A was surface area (cm2) (n = 1, D = 7.6 × 10–6 cm2 s−1 for [Fe(CN)6]3−) [67]. Thus, Bi2WO6/Bi2S3 composite was chosen for future sensor platform.
Fig. 4
A Cyclic voltammograms, B EIS reponses at (a) bare GCE, (b) Bi2WO6/GCE, (c) Bi2S3/GCE, (d) Bi2WO6/Bi2S3/GCE, (e) c-SARS-CoV-2-Ab1/Bi2WO6/Bi2S3/GCE, (f) BSA/c-SARS-CoV-2-Ab1/Bi2WO6/Bi2S3/GCE, (g) SARS-CoV-2 NP/BSA/c-SARS-CoV-2-Ab1/Bi2WO6/Bi2S3/GCE, (h) the final immunosensor including c-SARS-CoV-2-Ab1, SARS-CoV-2 NP, and d-SARS-CoV-2-Ab2 (scan rate of 50 mV s−1) in 1.0 mM [Fe(CN)6]3− containing 0.1 M KCl, and C DPV responses of the proposed immunosensors incubated with 0.2000 pg mL−1 SARS-CoV-2 NP using g-C3N4/WO3/d-SARS-CoV-2-Ab2 (curve b) in presence of 1.0 mM H2O2, g-C3N4/Au/WO3/d-SARS-CoV-2-Ab2 (curve c) in presence of 1.0 mM H2O2 and in absence of target analyte (curve a)
A Cyclic voltammograms, B EIS reponses at (a) bare GCE, (b) Bi2WO6/GCE, (c) Bi2S3/GCE, (d) Bi2WO6/Bi2S3/GCE, (e) c-SARS-CoV-2-Ab1/Bi2WO6/Bi2S3/GCE, (f) BSA/c-SARS-CoV-2-Ab1/Bi2WO6/Bi2S3/GCE, (g) SARS-CoV-2 NP/BSA/c-SARS-CoV-2-Ab1/Bi2WO6/Bi2S3/GCE, (h) the final immunosensor including c-SARS-CoV-2-Ab1, SARS-CoV-2 NP, and d-SARS-CoV-2-Ab2 (scan rate of 50 mV s−1) in 1.0 mM [Fe(CN)6]3− containing 0.1 M KCl, and C DPV responses of the proposed immunosensors incubated with 0.2000 pg mL−1 SARS-CoV-2 NP using g-C3N4/WO3/d-SARS-CoV-2-Ab2 (curve b) in presence of 1.0 mM H2O2, g-C3N4/Au/WO3/d-SARS-CoV-2-Ab2 (curve c) in presence of 1.0 mM H2O2 and in absence of target analyte (curve a)As expected, the obvious electrochemical sensor signals decreased owing to c-SARS-CoV-2-Ab1’s blocking effect on electron transfer (curve e of Fig. 4A). After the immobilizations of BSA (curve f of Fig. 4A) and SARS-CoV-2 NP (curve g of Fig. 4A), respectively, we observed that the sensor signals gradually decreased. Thus, it is concluded that the immobilization treatments of BSA and SARS-CoV-2 NP on electrode surface were successfully carried out. Finally, when the resulting immunosensor was used (curve h of Fig. 4A), further decrease on sensor signals was observed because of more antibody-nucleocapsid protein interactions.Secondly, EIS experiments were performed to prove CV results and according to Fig. 4B, the obtained charge transfer resistances were calculated as 75.0, 65.0, 55.0, 40.0, 85.0, 95.0, 125.0, and 140.0 Ω for bare GCE (curve a), Bi2WO6/GCE (curve b), Bi2S3/GCE (curve c), Bi2WO6/Bi2S3/GCE (curve d), c-SARS-CoV-2-Ab1/Bi2WO6/Bi2S3/GCE (curve e), BSA/c-SARS-CoV-2-Ab1/Bi2WO6/Bi2S3/GCE (curve f), SARS-CoV-2 NP/BSA/c-SARS-CoV-2-Ab1/Bi2WO6/Bi2S3/GCE (curve g), and the final immunosensor (curve h), respectively. Hence, the preparation procedure of immunosensor was completed successfully based on CV and EIS results.For electrochemical performance characterization (Fig. 4C) of the prepared signal amplification, several immunosensors using g-C3N4/WO3/d-SARS-CoV-2-Ab2 (curve b) and g-C3N4/Au/WO3/d-SARS-CoV-2-Ab2 (curve c) were developed by using 0.2000 pg mL−1 SARS-CoV-2 NP at the immune reaction time of 30 min and DPV signals were observed in 1.0 mM H2O2. As expected, the highest electrochemical performance was obtained by the immunosensor based on g-C3N4/Au/WO3/d-SARS-CoV-2-Ab2 in comparison with g-C3N4/WO3/d-SARS-CoV-2-Ab2. Because of the suppressing of electron transfer by g-C3N4/WO3 composite, a mediator such as AuNPs was needed at the interface for improving of electron transfer in Z-scheme heterojunction [59]. In addition, the stable electrochemical signals were observed by g-C3N4/Au/WO3/d-SARS-CoV-2-Ab2 owing to the strong covalent immobilization between g-C3N4/Au/WO3 and d-SARS-CoV-2-Ab2. Curve a of Fig. 4C also demonstrated that there was no electrochemical signal in absence of target analyte. To verify the specific interaction between antibody-nucleocapsid protein, SEM image (Fig. S4) of the resulting immunosensor indicating a spherical size and agglomeration was obtained, providing a successful immune reaction.
Optimization studies for electroanalytical characterizations
The effects of the solution pH, immune reaction time, H2O2, and g-C3N4/Au/WO3/d-SARS-CoV-2-Ab2 solution concentration were presented in detail (Fig. S5).
Linearity range
The obtained calibration equation by using SARS-CoV-2 NP concentrations and the observed electrochemical immunosensor signals was calculated as y = 47.231x + 1.0666, with a correlation coefficient of R2 = 0.9989, where y and x represented the current (µA) and SARS-CoV-2 NP concentration (pg mL−1), respectively (Fig. 5). The quantification limit (LOQ) and LOD were found to be 0.01 pg mL−1 and 3.00 fg mL−1, respectively. Equations (1) and (2) were employed to calculate LOQ and LOD:
Fig. 5
Concentration effect (from 0.01 to 1.00 pg mL−1 SARS-CoV-2 NP) on immunosensor signals, Inset: calibration curve for electrochemical SARS-CoV-2 NP immunosensor (potential range is + 0.0/ + 0.4 V; Parameters are frequency of 100 Hz, pulse amplitude of 25 mV, and scan increment of 5 mV)
Concentration effect (from 0.01 to 1.00 pg mL−1 SARS-CoV-2 NP) on immunosensor signals, Inset: calibration curve for electrochemical SARS-CoV-2 NP immunosensor (potential range is + 0.0/ + 0.4 V; Parameters are frequency of 100 Hz, pulse amplitude of 25 mV, and scan increment of 5 mV)In addition, Table 1 shows some comparison features between the developed sandwich-type electrochemical SARS-CoV-2 NP and the other new detection methods. Firstly, the sensitive SARS-CoV-2 NP detection (LOD: 3.00 fg mL−1) was performed in 30 min of immunological response time. More importantly, COVID-19 detection with high selectivity can be successfully performed from saliva samples by this immunosensor. In addition, thanks to the developed electrochemical SARS-CoV-2 NP immunosensor, the time-consuming steps in immunosensor development can be eliminated in this study. The preparation steps of Bi2WO6/Bi2S3 electrode platform and g-C3N4/Au/WO3 signal amplification comprised the minimal waste generation, indicating an immunosensor that is friendly to the environment and human health. As a result, the developed selective electrochemical SARS-CoV-2 NP immunosensor may offer a potential for early COVID-19 detection.
Table 1
The comparison of electrochemical SARS-CoV‑2 NP immunosensor with the other novel techniques
Material/method
Linear range
LOD
Assay time
Ref
Microfluidic
0.0–10.0 ng mL−1
50.0 pg mL−1
2 min
[68]
Paper-based electrochemical
1.0–1000.0 ng mL−1
1.0 ng mL−1
30 min
[7]
Chemiluminescence
0.2–100.0 ng mL−1
0.1 ng mL−1
16 min
[69]
Electrochemical/Cu2O nanocube
0.25 fg mL−1–1.00 µg mL−1
0.04 fg mL−1
20 min
[70]
Ni(OH)2 NPs
0.25 fg mL−1–1.00 µg mL−1
3.00 fg mL−1
20 min
[71]
Electrochemical immunosensor
0.01–1.00 pg mL−1
3.00 fg mL−1
30 min
This study
The comparison of electrochemical SARS-CoV‑2 NP immunosensor with the other novel techniques
Recovery
The recovery experiments including saliva samples obtained from five healthy individuals were carried out by the portable electrochemical SARS-CoV-2 NP immunosensor. Table S1 indicates the close values to 100.00% confirming the preparation of high selective electrochemical SARS-CoV-2 NP immunosensor. Moreover, standard addition method was applied to saliva samples obtained from five healthy individuals and y = 47.249x + 10.171, with R2 = 0.9994, was obtained as calibration equation. Thus, the close slope values between direct calibration (inset of Fig. 5) and standard addition methods again verified the high selective COVID-19 detection.The validity of the sandwich-type electrochemical immunosensor was evaluated by using colorimetric method [72]. Table S2 indicates the comparison results, showing that no significant difference was observed between the prepared immunosensor and colorimetric method (Tcalculated > Ttabulated, p > 0.05).
Selectivity, stability, reproducibility, and reusability
For selectivity measurement, the several electrochemical SARS-CoV-2 NP immunosensors were prepared by using different target dispersions such as (i) MERS-CoV NP + SARS-CoV NP + H1N1, (ii) SARS-CoV‑2 NP + MERS-CoV NP, (iii) SARS-CoV‑2 NP + SARS-CoV NP, (iv) SARS-CoV‑2 NP + H1N1. Then, these electrochemical immunosensors were applied to 1.0 mM H2O2 solution. Figure 6A confirms that the prepared electrochemical immunosensor demonstrated the high selectivity towards SARS-CoV‑2 nucleocapsid protein.
Fig. 6
A Immunosensor selective responses against the prepared solutions (n = 6): (i) 10.0 pg mL−1 MERS-CoV NP + 10.0 pg mL−1 SARS-CoV NP + 10.0 pg mL−1 H1N1, (ii) 0.2000 pg mL−1 SARS-CoV‑2 NP + 10.0 pg mL−1 MERS-CoV NP, (iii) 0.2000 pg mL−1 SARS-CoV‑2 NP + 10.0 pg mL−1 SARS-CoV NP, (iv) 0.2000 pg mL−1 SARS-CoV‑2 NP + 10.0 pg mL−1 H1N1; B Stability test of electrochemical SARS-CoV-2 NP immunosensor including 0.2000 pg mL−1 SARS-CoV-2 NP (n = 6) at 25.0 °C
A Immunosensor selective responses against the prepared solutions (n = 6): (i) 10.0 pg mL−1 MERS-CoV NP + 10.0 pg mL−1 SARS-CoV NP + 10.0 pg mL−1 H1N1, (ii) 0.2000 pg mL−1 SARS-CoV‑2 NP + 10.0 pg mL−1 MERS-CoV NP, (iii) 0.2000 pg mL−1 SARS-CoV‑2 NP + 10.0 pg mL−1 SARS-CoV NP, (iv) 0.2000 pg mL−1 SARS-CoV‑2 NP + 10.0 pg mL−1 H1N1; B Stability test of electrochemical SARS-CoV-2 NP immunosensor including 0.2000 pg mL−1 SARS-CoV-2 NP (n = 6) at 25.0 °CThe stability test results of the constructed electrochemical SARS-CoV-2 NP immunosensor at 25.0 °C for seven weeks were depicted in Fig. 6B. It was pointed out that the immunosensor signals were about 98.73% of the original electrochemical signal, indicating strong immunosensor stability.Finally, for reproducibility, 10 different electrochemical SARS-CoV-2 NP immunosensors were developed by the protocol which is explained in the “Electrochemical characterizations” section. The relative standard deviation (RSD) of 0.61 was calculated by using the observed 10 electrochemical signals, confirming the high reliability of immunosensor production procedure.Reusability of prepared electrochemical SARS-CoV-2 NP immunosensor was tested in 1.0 mM H2O2 solution. One SARS-CoV-2 NP immunosensor was utilized at least 30 times and 0.89% of RSD was obtained for current signals, confirming high reusability of prepared electrochemical SARS-CoV-2 NP immunosensor in this study.
Precision and accuracy
The studies of same day (intra-day precision) and six consecutive days (inter-day precision) were carried out in presence of three concentrations (0.3000, 0.5000, and 0.7000 pg mL−1 SARS-CoV‑2 NP) in linearity range (Table S3). The values of RSD for intra-day and inter-day precision were obtained as 0.070–0.098 and 0.035–0.098, respectively. Hence, low RSD verified high precision of prepared electrochemical SARS-CoV-2 NP immunosensor. Accuracy as Bias % was also tested and low Bias % (Table S3) suggested the high accuracy of electrochemical SARS-CoV-2 NP immunosensor.
Conclusions
COVID-19 pandemic has caused important damage to society. Until now, many kits for SARS-CoV-2 sensing have been developed. For first time, sensitive electrochemical SARS-CoV‑2 nucleocapsid protein immunosensor based on Bi2WO6/Bi2S3 as electrode platform and g-C3N4/Au/WO3 as signal amplification was presented in this work. This immunosensor was constructed by c-SARS-CoV-2-Ab1 immobilization via strong electrostatic interaction and d-SARS-CoV-2-Ab2 incubation via gold-amino affinity. Thus, the stable electrochemical signals were accomplished in terms of COVID-19 disease detection. In addition, the prepared electrochemical immunosensor had good ability in selective detection of SARS-CoV‑2 nucleocapsid protein. In spite of these advantages, the presented detection protocol was a little time consuming in immunological response time (30 min), indicating that this analysis time is significant in terms of faster diagnosis. Furthermore, the prepared immunosensor based on Bi2WO6/Bi2S3 and g-C3N4/Au/WO3 was reproducible and reusable biosensor and did not include in time-consuming steps such as sensor preparation. Finally, this developed immunosensor can be easily integrated into a commercial biosensor tool and used for the determination of the other viral diseases.Below is the link to the electronic supplementary material.Supplementary file1 (DOC 610 KB)